Medicare's Tunis "on leave", pending CME hours claims
This article was originally published in Clinica
Sean Tunis, the high-ranking Medicare official who played a major role in deciding whether to extend coverage for surgically-implanted defibrillators, has been placed on administrative leave for allegedly falsifying personal documents.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.